Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: Pharmacokinetic analysis and correlation to tumor histomorphology
Authors:
- Tormod A.M. EgelandTETormod A.M. Egeland
- Kanthi GalappathiKGKanthi Galappathi
- Einar K. RofstadEREinar K. Rofstad
- 1 November 2010
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 97 (2) , 217-224
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Predicting Control of Primary Tumor and Survival by DCE MRI During Early Therapy in Cervical CancerInvestigative Radiology, 2009
- Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapyThe Lancet Oncology, 2007
- Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd‐DTPA‐enhanced MR imagingJournal of Magnetic Resonance Imaging, 2001
- Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysisThe Lancet, 2001
- Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervixRadiotherapy and Oncology, 2000
- Dynamic Contrast-enhanced MR Imaging of Uterine Cervical Cancer: Pharmacokinetic Analysis with Histopathologic Correlation and Its Importance in Predicting the Outcome of Radiation TherapyRadiology, 2000
- Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularizationRadiotherapy and Oncology, 2000
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerNew England Journal of Medicine, 1999
- Oxygenation predicts radiation response and survival in patients with cervix cancerRadiotherapy and Oncology, 1998
- Carcinoma of the cervix: dynamic MR imaging.Radiology, 1992